Cannabis Law Report

JULY 13, 2022

Import, Advertising and Supply Compliance Priorities 2022-23. The table below sets out the TGA’s priority areas for compliance activities relating to the import, advertising and supply requirements of the Therapeutic Goods Act 1989 from 1 July 2022 to 30 June 2023. Import, Advertising and Supply Compliance Priorities 2022-23.

Compliance 52

Compliance Compliance Wellness and Beauty Vaping 52

NORML

FEBRUARY 22, 2019

Passage of this legislation is important because the Arizona Court of Appeals recently ruled that patients who rely on these products are not protected under the law and could face felony penalties for simply using their medicine. Update : HB 2149 was approved by the Public Safety Committee on 2/20. AZ resident? Connecticut. CT resident?

Legislation 186

Legislation Hemp Compliance Compliance 186

MJ Business Attorneys

JUNE 29, 2018

The FDA’s approval of the drug is just one step toward getting Epidiolex on the market and available to doctors to prescribe as a treatment option. As the Controlled Substances Act (CSA) currently stands, CBD is still a Schedule I substance, which classifies CBD as having no medicinal uses.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

MMJ Recs

JULY 9, 2024

Traditional treatments, while helpful to some extent, often come with limitations and side effects that can further burden individuals already dealing with a debilitating disease. Medical marijuana has emerged as a promising alternative treatment option for managing symptoms associated with MS.

Marijuana 111

Marijuana Treatment Cannabinoids Patients 111

Cannabis Law Report

MAY 18, 2022

Psychedelic medicine group (MAPS) investigating a board member accused of financial elder abuse. MAPS’ compliance team will review the allegations, spokesperson Betty Aldworth wrote in an email to STAT. Psychedelic medicine group investigating a board member accused of financial elder abuse. BACKGROUND. Stat News reports.

Medicine 52

Medicine Compliance Compliance Treatment 52

Cannabis Law Report

SEPTEMBER 16, 2021

A new group set up to explore the benefits of medicinal cannabis has been set up, led by a Glasgow MSP. The Scottish Parliament’s new Cross Party Group on Medicinal Cannabis met for the first time this week. It has been set up jointly by Pauline McNeill, Glasgow Labour MSP and Rona Mackay, SNP MSP for Strathkelvin and Bearsden.

Medicine 52

Medicine Research and Development Treatment Conditions 52

Cannabis Law Report

AUGUST 3, 2021

42 of July 9, 2017, also known as the Act to Manage the Study, Development and Research of Cannabis for Innovation, Applicable Standards and Limits (Medicinal Cannabis Act). Act 15 amends Act No. This amendment expands employment protections to employees who are registered and licensed medical cannabis patients.

Patients 105

Patients Law Research and Development Medicine 105

United Patients Group

JULY 7, 2023

Cannabis has been used for medicinal purposes for thousands of years, dating back to ancient civilizations in Asia, Africa, and the Americas. 3) Helps Manage Nausea and Vomiting Medical cannabis can be used to manage nausea and vomiting associated with chemotherapy, radiation therapy, and other medical treatments.

Chronic Pain 105

Chronic Pain Sleep Epilepsy Conditions 105

Cannabis Law Report

AUGUST 2, 2021

42 of July 9, 2017, also known as the Act to Manage the Study, Development and Research of Cannabis for Innovation, Applicable Standards and Limits (Medicinal Cannabis Act). Act 15 amends Act No. This amendment expands employment protections to employees who are registered and licensed medical cannabis patients.

Patients 98

Patients Law Research and Development Medicine 98

Veriheal

JANUARY 18, 2024

They position cannabis as a legitimate and valuable treatment option within the broader medical community. She noted: “Nurses are the largest group of health professionals, providing an opportunity to change the health care paradigm and include diverse wellness modalities beyond traditional Western medicine.

Education 116

Education Therapy Patients Research and Development 116

Cannabis Law Report

OCTOBER 1, 2021

The first legal medicinal cannabis product will be available to eligible patients from next month, but a specialist consultant has said he would not prescribe it due to the absence of a scientific evidence base for its efficacy. The Irish Times reports.

Medicine 52

Medicine Epilepsy Legalization Patients 52

Cannabis Law Report

JULY 15, 2021

Kanabo (LON:KNB) , the medical cannabis company, confirmed on Wednesday that its medicinal cannabis cartridges will soon be available for UK patients. Proactive reported that market experts have said it is the first time a medicinal extract formula has been made available for inhalation by a metered-dose medical-grade vaporiser in Britain.

Extraction 81

Extraction Medicine Terpenes Treatment 81

Cannabis Law Report

AUGUST 20, 2021

In an opinion piece published in The Times today , Conservative MP Dan Poulter, a practising NHS doctor, wrote that the drug has a lot of medical benefits – including the treatment of chronic pain, reduction of nausea for patients undergoing chemotherapy, and as a therapy for poor sleep and anxiety disorders.

Policy 105

Policy Chronic Pain Medicine Therapy 105

Peninsula Alternative Health

MARCH 1, 2018

The physician advocate outlines practice risks and benefits, educational requirements, compliance issues, and more for those interested in studying this alternative treatment. These organizations are great resources for patients who are thinking about using medicinal cannabis and for physicians who practice this alternative treatment.

Treatment 40

Treatment Education Advocacy Access 40

Peninsula Alternative Health

MARCH 1, 2018

The physician advocate outlines practice risks and benefits, educational requirements, compliance issues, and more for those interested in studying this alternative treatment. These organizations are great resources for patients who are thinking about using medicinal cannabis and for physicians who practice this alternative treatment.

Treatment 40

Treatment Education Advocacy Access 40

MMJ Recs

MAY 25, 2024

However, in recent years, there has been a shift in attitudes towards cannabis, driven by increasing recognition of its medicinal properties and mounting evidence supporting its therapeutic benefits. However, further studies are needed to fully understand the mechanisms and potential of ECS modulation in mental health treatment.

Patients 105

Patients Marijuana Cannabinoids Chronic Pain 105

Cannabis Law Report

AUGUST 21, 2019

Cannabis treatments are too expensive and do not come with enough test evidence to be effective, UK authorities have said. The National Institute for Health and Care Excellence (NICE) reviewed evidence for the benefits and costs of cannabis-based medicinal products and drew up guidance for health professionals and the public.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81

The Cannigma

MAY 21, 2021

Were you receiving treatment of any kind for your ADD at the time or before you came to this realization? It took me I would say a good year or so of experimentation to realize an oil-based whole-plant THC tincture at very low dose was the right strategy for me from a medicinal standpoint. It’s not like I love my medicine.

Education 133

Education Programs Research and Development Cannabis 133

Cannabis Law Report

JUNE 23, 2021

COPENHAGEN , June 22, 2021 /PRNewswire/ — Valcon Medical A/S (“Valcon Medical” or the “Company”), Denmark’s leading independent cannabis concentrate and medical formulation provider, received its licensing for the commercial production of cannabis from the Danish Medicines Agency (DKMA) earlier in May 2021.

Pharmaceutical 86

Pharmaceutical Concentrates Extraction Medicine 86

Cannabis Law Report

APRIL 1, 2022

Aguilar has suggested that “cannabis must have similar authorization and use conditions” to those that operate in Spain with products such as morphine and has opened the door for, at one time, community pharmacies -and not just hospital ones- dispense cannabinoid-based products that the Medicines Agency may authorize.

Medicine 52

Medicine Data Safety Conditions 52

Cannabis Law Report

NOVEMBER 18, 2019

percent THC as long as the production was in compliance with all legal requirements. Since November 2015, the Italian Ministry of Health may issue permits to cultivate cannabis for medicinal purposes with a THC content in excess of 0.2 EU subsidies are available for crops that do not exceed 0.2

Supply Chain 77

Supply Chain Chronic Pain Consumption Cultivation 77

Cannabis Law Report

JULY 9, 2021

– Canadian parent has remained in compliance with all FDA registrations and international guidelines. or under private label, is safe to use until the expiration date and remains in full compliance with all regulatory bodies. . – Restructured U.S. subsidiary removes $7.2 million of debt and future obligations.

Compliance 104

Compliance Compliance Business Conditions 104

Cannabis Law Report

NOVEMBER 29, 2019

Euractiv report… Germany’s regulatory approach to medical cannabis is good practice and should be replicated across Europe, according to newly-born European Medicinal Cannabis Association (EUMCA). Lack of clinical trials is a major reason why doctors are cautious about the drug. Read full story.

Medicine 45

Medicine Clinical Trials Treatment Access 45

MMJ Recs

MARCH 16, 2024

With increasing acceptance of medical marijuana as a legitimate treatment option for various health conditions, the industry has attracted significant attention from investors, entrepreneurs, and policymakers alike. Market size refers to the total value of medical cannabis sales, encompassing both medicinal and adult-use markets.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Medicinal Genomics

APRIL 9, 2025

Without proactive monitoring and an integrated pest management (IPM) strategy, cultivators may face crop loss as well as increased costs from remediation efforts, regulatory compliance issues, and potential damage to brand reputation. The post Increase Cannabis Yield with Proven Techniques appeared first on Medicinal Genomics.

Environment 69

Environment Cultivation Research and Development Terpenes 69

Cannabis Law Report

AUGUST 19, 2021

Cantourage has successfully partnered with Australian-based Cannim, the leading cultivator of medicinal cannabis in Jamaica. Through the introduction of new cultivars, Cantourage and Cannim are providing new treatment options for patients in Europe.

Access 98

Access Cultivation Patients Indica 98

Cannabis Law Report

JULY 5, 2021

Dr Poulter, a former health minister, said: “As a doctor, I am increasingly aware of the potential of cannabis-based medicines. Avihu Tamir, chief executive Kanabo Group, said: “Dan brings a wealth of knowledge and insight into the business that strengthens our team as we build a medicinal cannabis market in the UK and Europe.”

Research and Development 81

Research and Development Chronic Pain Medicine Vaping 81

MMJ Recs

FEBRUARY 21, 2024

Healthcare providers can offer guidance on potential benefits, risks, and interactions with existing treatments. Understanding the legal and regulatory landscape is essential to ensuring compliance and responsible use. Legal and Regulatory Considerations: The legal status of medical marijuana varies globally and within regions.

Chronic Pain 105

Chronic Pain Marijuana Research and Development Cannabinoids 105

Cannabis Law Report

APRIL 1, 2019

It was further reported by New Cannabis Ventures on February 28 th , 2019 that Jacana has completed the first-ever international export of Jamaican medicinal cannabis flower, securing multiple international licenses and permits to date.

Medicine 40

Medicine Legalization Decriminalization Law 40

Cannabis Law Report

SEPTEMBER 11, 2021

They discussed decriminalisation, prosecution, and medicinal products. He said, although he had “no issue” with the prescription of medicinal cannabis for certain conditions, he was unsure about legalising it for recreational use. image caption Daphne Caine says the island’s laws fall behind other countries.

Cannabis 104

Cannabis Recreational Medicine Law 104

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD.

Clinical Trials 52

Clinical Trials Research and Development Therapy Compliance 52

Cannabis Law Report

SEPTEMBER 10, 2019

Tabling of Report on the Review into the 2016 Medicinal Cannabis amendments to the Narcotic Drugs Act 1967. The Final Report contains 26 recommendations to improve the regulatory framework for the cultivation, production and manufacture of medicinal cannabis in Australia. Adoption of a national medicinal cannabis scheme in Australia.

Medicine 49

Medicine Research and Development Cultivation Access 49

Cannabis Law Report

OCTOBER 4, 2021

Individual fined $18,648 for alleged advertising breaches relating to medicinal cannabis products. The TGA alleges that the individual also made a prohibited representation , on a related social media platform, in relation to the use of CBD oil for the treatment of cancer. Here’s the TGA announcement. 28 September 2021.

Law 52

Law Treatment Medicine CBD 52

Cannabis Law Report

AUGUST 15, 2019

Luxembourg had previously legalised cannabis for medicinal purposes, and recreational use was partially decriminalised for small amounts, although growing, selling and producing the drug remains a criminal activity punishable by law. Prohibiting products has made them more attractive to young people.

Recreational 75

Recreational Medicine Legislation Education 75

Cannabis Law Report

JANUARY 27, 2022

will exporters to Australia all rush to be GMP compliant or will they just determine that costs of compliance are too high and thus look for other markets which in turn will reduce the availability of product in the Australian medical market. The question is. We suggest the latter. MJ Biz write.

Packaging 52

Packaging Compliance Compliance Access 52

Cannabis Law Report

SEPTEMBER 29, 2022

Medicinal cannabis companies that falsely claimed their prescription products could treat serious conditions, such as cancer and epilepsy, have received a collective fine of almost $1m by Australia’s drugs regulator. Three medicinal cannabis companies fined almost $1 million for alleged unlawful advertising. Read more at.

Epilepsy 52

Epilepsy Conditions Media Medicine 52

The Blunt Truth

APRIL 20, 2021

The term does not include industrial hemp, as defined in state law, that is grown, dealt, or processed in compliance with state or federal law, unless it has been acquired and formulated with cannabis plant extract by a pharmaceutical processor.

Recreational 77

Recreational Legalization Oil Extraction 77